Your browser doesn't support javascript.
loading
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
Gravina, Giovanni Luca; Mancini, Andrea; Mattei, Claudia; Vitale, Flora; Marampon, Francesco; Colapietro, Alessandro; Rossi, Giulia; Ventura, Luca; Vetuschi, Antonella; Di Cesare, Ernesto; Fox, Judith A; Festuccia, Claudio.
Afiliação
  • Gravina GL; Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy, University of L'Aquila, L'Aquila, Italy.
  • Mancini A; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy.
  • Mattei C; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy.
  • Vitale F; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Neurosciences, University of L'Aquila, L'Aquila, Italy.
  • Marampon F; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Neurosciences, University of L'Aquila, L'Aquila, Italy.
  • Colapietro A; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy.
  • Rossi G; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy.
  • Ventura L; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L'Aquila, L'Aquila, Italy.
  • Vetuschi A; Department of Biotechnological and Applied Clinical Sciences, Laboratory of Neurosciences, University of L'Aquila, L'Aquila, Italy.
  • Di Cesare E; Department of Biotechnological and Applied Clinical Sciences, Chair of Human Anatomy, University of L'Aquila, L'Aquila, Italy.
  • Fox JA; Department of Biotechnological and Applied Clinical Sciences, Division of Radiotherapy, University of L'Aquila, L'Aquila, Italy.
  • Festuccia C; Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA.
Oncotarget ; 8(18): 29865-29886, 2017 May 02.
Article em En | MEDLINE | ID: mdl-28415741

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Tiazóis / Glioblastoma / Naftiridinas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tolerância a Radiação / Tiazóis / Glioblastoma / Naftiridinas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article